P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33

Area of Science:

• Immunology
• Cell Biology
• Inflammation Research

Background:

• Mast cells (MCs) are key immune cells in barrier tissues, responding to damage signals like IL-33.
• Adenosine triphosphate (ATP) released at injury sites modulates MC activity.

Purpose of the Study:

• To investigate how IL-33 influences ATP-mediated mast cell activation.
• To identify the specific purinergic receptors involved in this interaction.

Main Methods:

• Human primary MCs were primed with IL-33.
• Responses to ATP and ADP were measured, including degranulation, IL-8 release, and signaling pathways (pERK1/2).
• Selective P2X receptor inhibitors (P2X1, P2X4, P2X7) were used to determine receptor roles.

Main Results:

• IL-33 priming significantly enhanced MC responses to ATP, but not ADP.
• This resulted in increased degranulation, IL-8 release, and pERK1/2 signaling, effects specific to IL-33.
• IL-33 increased P2X receptor expression on MCs, with P2X7 identified as critical for ATP-induced ERK1/2 signaling and degranulation.

Conclusions:

• IL-33 primes human mast cells to be more responsive to ATP.
• The P2X7 receptor is a key mediator of enhanced ATP-induced mast cell degranulation and signaling following IL-33 stimulation.
• These findings elucidate mechanisms of IL-33 in modulating mast cell responses in inflammatory environments.